BALB/c murine sarcoma virus (BALB-MSV) is a replication-defective transforming retrovirus of mouse origin (1, 15) that was isolated from a spontaneously occurring BALB/c mouse tumor. Recent studies have demonstrated that BALB-MSV arose by recombination between a murine leukemia virus and a mouse cell DNA sequence (4) . Molecular cloning and detailed structural analysis of the proviral genome of BALB-MSV have revealed that large portions of helper virus pol and env genes were deleted as a result of this recombination and were replaced by a stretch of cellular sequences ca. 0.6 kilobase long (4) . The molecularly cloned BALB-MSV cell-derived sequence, v-bas, exhibited a high degree of sequence homology with the transforming gene (H-ras) of Harvey murine sarcoma virus, as determined by heteroduplex and Southern blot hybridization analyses (3) . The importance of the ras family of oncogenes has been highlighted by recent discoveries that the majority of the dominant transforming genes isolated from human tumors are closely related to these retroviral oncogenes (7, 10, 14, 16, 24, 26) . In fact, a series of recent advances in this area has demonstrated that single point mutations in either of two specific codons frequently lead to the activation of ras proto-oncogenes as oncogenes (5, 6, 18, 19, 25, 27-29, 35, 36) .
In an effort to understand the structural relationships between the oncogenes of BALB-MSV and Harvey murine sarcoma virus and their human cellular counterparts, we carried out primary nucleotide sequence analysis of these genes. In this paper we present the nucleotide sequence of the BALB-MSV transforming gene.
Molecular cloning and preliminary characterization of the BALB-MSV proviral genome were described earlier (4). The clone (X9EB-18) contained the entire proviral genome and adjacent host cellular sequences. Portions of the proviral genome were subcloned in the plasmid vector pBR322 and used for sequencing. One subclone, designated pHBI (4), contained almost the entire v-bas sequence. Another subclone used contained the viral sequences immediately upstream of pHBI, located between the two HindIll sites [ Fig. 1]) .
To map in greater detail the regions of the helper virus that underwent deletions or substitutions or both during the recombinational events that generated BALB-MSV, we carried out heteroduplex analysis between the BALB-MSV proviral genome and that of a mouse helper virus, Rauscher murine leukemia virus (R-MuLV) (11) , which is closely related to the natural helper virus present in the original BALB-MSV isolate (R. P. Reddy, unpublished data). A representative heteroduplex structure is shown in Fig. 2 . Such an analysis revealed that the two viral genomes shared 3.7 ± 0.2 kbp of homologous sequences at their 5' ends. This region of homology represents the long terminal repeat, the entire gag sequence, and the amino-terminal region of the polymerase gene of the R-MuLV genome (11) . Following this region, a deletion loop of ca. 1.7 ± 0.2 kbp was observed and was deduced to represent the polymerase gene sequences of the helper virus deleted in BALB-MSV. This feature was followed by a second region of homology 0.62 ± 0.05 kbp long which could have been derived from either the carboxy-terminal region of the polymerase gene of R-MuLV or the amino-terminal region of the envelope gene of RMuLV or both. Downstream of this, a sequence substitution bubble was observed. From the restriction maps of R-MuLV and BALB-MSV, we could conclude that 0.85 ± 0.1 kbp of env sequences were replaced by the 0.70 ± 0.1-kbp v-bas of host cellular origin. At the 3' end, the substitution was followed by a homologous region of 2.2 ± 0.2 kbp which must represent the carboxy-terminal region of the env gene and the 3' long terminal repeat. Thus, the generation of BALB-MSV involved a large deletion in the helper virus pol gene and a substitution of the env gene with v-bas.
The nucleotide sequence of the transforming region of BALB-MSV is shown in Fig. 3 . To precisely localize the points of recombination, we compared the sequences shown in Fig. 3 with those of AKR murine leukemia virus (12) by using the computer program developed by Wilbur and Lipman (34) . This analysis revealed that the BALB-MSV sequence ( Fig. 3) murine leukemia virus sequences. The sequence comparison also demonstrated that the host-derived sequences (positions 45 through 749) underwent recombination with the helper virus such that they were flanked by the pol gene carboxy-terminal sequences at the 5' end and by the env gene carboxy-terminal sequences at the 3' end. The recombination resulted in the deletion of 63 codons from the 3' end of the pol gene and a deletion of the amino-terminal 735 nucleotides coding for the first 245 amino acids of the env gene. However, the putative acceptor splice signal used in the generation of subgenomic env mRNA was retained. It is possible that a similar splicing mechanism mnay be used to generate the mRNA of the BALB-MSV transforming gene. Examination of the cell-derived sequences upstream of the first ATG codon did not reveal any apparent promoter-like sequences in this region, suggesting transcription via a spliced mRNA.
The transforming gene product of BALB-MSV has been identified as a 21,000-dalton protein (3), and examination of the sequence revealed the presence of an open reading frame starting at positions 144 through 146 and extending for 567 nucleotides, that could encode a protein of 189 amino acids with a molecular weight of ca. 21,000. The predicted amino acid sequence for this protein is shown in Fig. 3 .
The high degree (97%) of nucleotide sequence similarlity between the v-bas open reading frame and that of v-H-ras (9) formally established that v-bas indeed arose from the mouse homologue of the H-ras-1 proto-oncogene. Furthermore, there were only three differences in the predicted p21 amino acid sequences of v-bas and v-H-ras; these were, respectively, lysine versus arginine at position 12, alanine versus threonine at position 59, and lysine versus glutamic acid at position 143. Recent studies with several acute transforming viruses have revealed that the proto-oncogenes have undergone extensive deletions in their amino-or carboxy-terminal regions or both during recombination with the helper virus.
Thus, in the case of Moloney murine sarcoma virus (21, 32) and simian sarcoma virus (8) , it was demonstrated that the present. The only differences between the sequences predicted for the p21 proteins of BALB-MSV and the T24 human oncogene are at positions 12 and 143 (valine and glutamic acid, respectively, in T24) (6, 18, 19, 25, 27-29, 35, 36) . The HI-ras-1 (human) proto-oncogene encodes glycine and glutatnic acid at positions 12 and 143, respectively (18). The nucleotide sequence of H-ras-1 (mouse) has not yet been determined. Thus, whether the lysine at position 143 in the BALB-MSV transforming gene plays any role in its activation is not known. However, extensive evidence for the acquisition of transforming properties by ras oncogenes as a result of mutations at position 12 strongly implies that this lesion alone is responsible for the oncogenic activity of BALB-MSV p21.
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